A comprehensive view of Insulet Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Insulet’s Omnipod 5 tubeless automated insulin delivery system for kids two years old and older with type 1 diabetes; Omnipod 5 integrates Dexcom G6 CGM system to automatically adjust insulin, protect against high and low glucose levels
Published: August 24, 2022 by Business Wire
Sustainability & Social Responsibility: Insulet 2021 Sustainability Report
Published: May 16, 2022 by Insulet Corp.
Insulet releases 2021 sustainability report; highlights include 100% fulfillment of customer orders via dual and local sourcing while in Europe, UK, Canada, Insulet diverted over 135 metric tons of Omnipod Pods from landfills via product takeback programs
Published: May 13, 2022 by Insulet Corp.
Insulet reports Q1 net income of US$27.8M from US$0.0M a year ago, with revenue up 17.1% year-over-year at US$295.4M; US revenue of Omnipod 5 automated insulin delivery system up 21.5% after limited launch in country, with full market release this year
Published: May 09, 2022 by Insulet Corp.
Insulet names Jim Hollingshead, Ph.D. as President, CEO, to succeed Shacey Petrovic, who is stepping down from the position on June 1; Dr. Hollingshead currently serves as President of Sleep and Respiratory Care at ResMed, Inc.
Published: May 09, 2022 by Insulet Corp.

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count